Skip to main content

Table 2 Univariate analysis of factors associated with 90-day readmission in veterans with IBD

From: Risk factors for 90-day readmission in veterans with inflammatory bowel disease—Does post-discharge follow-up matter?

Item

No readmission

90-day readmission

P value

Age (year, x ± s)

59.2 ± 15.6

61.4 ± 13.1

0.31

Male (n (%))

138 (96.5)

59 (100)

0.15

Caucasian (n (%))

128 (89.5)

57 (96.6)

0.10

History of psychiatric disorder (n (%))

74 (51.7)

42 (71.2)

0.01

Type of IBD (n (%))

  

< 0.001

 Crohn’s disease

78 (54.5)

48 (81.4)

 

 Ulcerative colitis

65 (45.5)

11 (18.6)

 

Duration of IBD (year, median(IQR))

16 (7-30)

16 (3-34)

0.84

History of bowel resection (n (%))

95 (66.4)

39 (66.1)

0.96

IBD medication prior to admission (n (%))

 5-ASA

51 (35.7)

15 (25.4)

0.16

 Immunomodulator (AZA/6-MP or MTX)

29 (20.3)

15 (25.4)

0.42

 Anti-TNF

18 (12.6)

6 (10.2)

0.63

 Steroids

25 (17.5)

15 (25.4)

0.20

Psychiatric/pain medication prior to admission (n (%))

 Benzodiazepine

24 (16.8)

9 (15.3)

0.79

 Narcotics

57 (39.9)

28 (47.5)

0.32

 Antidepressant

47 (32.9)

33 (55.9)

0.002

Medication at discharge (n (%))

 Change in IBD medication at discharge

32 (22.4)

23 (39)

0.02

 Benzodiazepine at discharge

22 (15.4)

8 (13.6)

0.74

 Narcotics at discharge

75 (52.4)

29 (49.2)

0.67

 Discharge to home (n (%))

135 (94.4)

51 (86.4)

0.06

Complication during hospitalization (n (%))

 Surgical procedures during admission

28 (19.6)

10 (16.9)

0.66

 ICU stay

6 (4.2)

3 (5.1)

0.78

 Nosocomial infection

6 (4.2)

2 (3.4)

0.79

 Venous thromboembolism

1 (0.7)

1 (1.7)

0.52

 Length of hospitalization (day, median (IQR))

4 (2-6)

4 (2-8)

0.84

Follow-up after hospitalization (n (%))

 Mention of follow-up with PCP in discharge summary/nurse note

71 (49.7)

32 (54.2)

0.55

 Follow-up with PCP clinic within 90 days

74 (51.7)

16 (27.1)

0.001

 Mention of follow-up with GI in discharge summary/nurse note

67 (46.9)

31 (52.5)

0.46

 Follow-up in GI clinic within 90 days

67 (46.9)

18 (30.5)

0.03

  1. IBD inflammatory bowel disease, IQR interquartile range, PCP primary care physician, TNF tumor necrosis factor, ICU Intensive care unit, GI gastroenterologist